Cardiovascular Disease Research
The Kardiologijos ir reabilitacijos klinika UAB conducts studies aimed at preventing and treating cardiovascular disease. Trials address patients at high risk of events, explore new therapies to lower the incidence of major adverse cardiovascular events, and evaluate interventions for heart failure with reduced ejection fraction.
- Primary prevention of atherosclerotic cardiovascular disease
- Management of heart failure with reduced ejection fraction
- Reduction of elevated lipoprotein(a) levels
With two investigators overseeing six active trials, the site is advancing innovative treatments that could improve outcomes for patients with heart conditions and high‑risk profiles.
Nutritional and Metabolic Disease Research
Research at the clinic also targets nutritional and metabolic diseases, focusing on disorders that increase cardiovascular risk. Studies evaluate novel agents designed to lower triglyceride levels and enhance lipid‑lowering strategies in individuals with severe hypertriglyceridemia.
- Severe hypertriglyceridemia management
- Optimization of lipid‑lowering therapy
- Impact of metabolic interventions on cardiovascular outcomes
The multidisciplinary team leverages its expertise to test therapies that may reduce metabolic risk factors and support overall heart health.
